US Pharma Lab LLC has signed a pre-construction, full-building lease agreement with SL Industrial Partners, a member of the Silverman Group, The nearly 163,000-square-foot build-to-suit facility at the North Brunswick Logistics Center will be US Pharma Lab’s third location in New Jersey. Silverman’s internal general contractor, Silver Line Development, will custom-build the facility as well as handle the necessary custom medical outfitting, which includes cleanrooms and controlled environments. The anticipated completion of the project is fall 2025.
To make room for the new building at 2 King Arthur Court, Silverman demolished a longtime Johnson & Johnson office building. The North Brunswick Logistics Center is one piece of the much larger SL Corporate Center, a redevelopment of a former J&J campus acquired by Silverline Windows. The 100-acre corporate center features light manufacturing, distribution, office, and warehouses. Cornerstone Building Products is the anchor tenant, occupying over 800,000 square feet.
“Securing a full-building, build-to-suit lease with a prestigious company like US Pharma Lab underscores the strategic value of our new project and the quality of industrial space we’re delivering, while also reinforcing New Jersey’s position as a hub for innovative manufacturing and distribution,” commented Blake Silverman, President of The Silverman Group. ”We’re excited to support US Pharma Lab’s expansion and contribute to the local economy.”
US Pharma Lab is a global leader in the development and manufacturing of premium dietary supplement ingredients, premixes and products. The new facility will be close to the firm’s North Brunswick headquarters and will allow the organization to expand manufacturing and distribution capacity.
“We are excited to partner with an established developer such as Silverman Group for our next chapter in expanding our growth in the U.S. This collaboration marks a significant milestone, enabling us to create a state-of-the-art built-to-suit facility tailored to our specific needs. With this new facility, we will significantly increase our operational capacity, enhancing our efficiency and responsiveness to better serve our customers,” said Amol Luhadia, CEO of US Pharma Lab. “We look forward to working closely with Silverman Group to bring this vision to life.”
Michael Kimmel of KBC Advisors represented US Pharma Lab in the lease transaction, while the landlord was represented by their in-house leasing team.
